Pet owners increasingly expect the same standards of precision health for their pets that they’ve come to expect for themselves: clinically-validated ingredients with targeted outcomes.

That shift is pulling human clinical science directly into pet formulation, and nowhere is the opportunity clearer than the microbiome where strains studied for specific human outcomes are now being asked to prove themselves in pets too.

Whether it’s oral health, digestive health, or both together, brands have a growing toolkit of clinically-backed options to meet that demand.

This webinar unpacks that shift: the scale of the oral health opportunity in pets, the clinical science behind BLIS’s oral microbiome approach and Probi’s LP6595 gut research, and how translatable human data is becoming the trust signal pet brands need as consumer expectations rise.